Switch of AndroidAPS to Commercially Available AID Systems

Charles University, Czech Republic

Status: Active, not recruiting

Conditions: Diabetes Mellitus, Type 1

Treatments: Device: Insulin pump with closed-loop system

Study type: Interventional

Funder types: Other

Identifiers

NCT06709729

CODIAC Extension

Details and patient eligibility

About

The aim of the study was to investigate the switch between open-source automated insulin delivery system (OS-AID) - AndroidAPS (AAPS) and commercially available AID systems - Control-IQ (CIQ) and MiniMed 780G (780G) in extended follow-up study.

Enrollment: 41 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• type 1 diabetes diagnosed >2 years
• ≥ 18 years old
• written informed consent prior to starting study related activity
• previous user of AndroidAPS at least for 3 months

Exclusion criteria

• nonadherence to the current treatment regimen
• lactation
• pregnancy
• intending to become pregnant during study
• concomitant therapy influencing glucose metabolism

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Sequential Assignment

Masking: None (Open label)

---

41 participants in 1 patient group

Control-IQ or Smartguard system

Experimental group

Description:

Patients with use of the Control-IQ system or Smartguard system (closed-loop hybrid system) and previous users of AndroidAPS (closed-loop hybrid system)

Treatment:

Device: Insulin pump with closed-loop system